Lobe Sciences Ltd.
LOBEF
$0.08
-$0.01-6.21%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -99.28% | 53.59% | -101.97% | -42.50% | 15.58% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.67% | -220.51% | 1,100.99% | -125.72% | -47.32% |
| Change in Net Operating Assets | -126.47% | -25.99% | 86.37% | 276.80% | -35.72% |
| Cash from Operations | -264.07% | -42.70% | -0.10% | -13.13% | -45.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -543.26% | 138.54% | -- | -- | -- |
| Cash from Investing | -543.26% | 138.54% | -- | -- | -- |
| Total Debt Issued | -- | -- | -200.14% | 4,519.87% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -48.40% | -61.04% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 3,415.32% | -200.00% | -- |
| Cash from Financing | -100.00% | 773.17% | -99.93% | 1,875.64% | -- |
| Foreign Exchange rate Adjustments | -37.14% | 113.94% | -230.05% | 143.86% | -296.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,763.15% | 106.39% | -127.28% | 627,877.78% | 99.42% |